Description
Global Endoprosthesis Market-Forecast till 2027
Endoprosthesis Market Overview
The global endoprosthesis market is anticipated to witness a healthy CAGR of 11.50% during the review period. Endoprosthesis is a treatment that includes utilizing an embed to supplant a joint in the body that has lost working capacities because of harm or disease. Degenerative joint sickness, cracks, and malignancies are for the most part normal signs that an endoprosthesis ought to be utilized.
The global endoprosthesis market accounted for USD 20,679.25 million in 2020 and is estimated to surpass USD 45,134.19 million by 2027. The expansion of the global endoprosthesis market is attributed to the elements like the expanding pervasiveness of osteoarthritis among the geriatric populace, mechanical headways in endoprosthesis gadgets empowering successful treatment, and expanding mindfulness among the populace.
Besides, unfavourable impacts and significant expenses related to endoprosthesis and lack of healthcare infrastructure and unaffordability in emerging countries are set to limit the endoprosthesis market development in the future.
Market Segmentation
The global endoprosthesis market based on products has been classified as knee, Hip, Shoulder, Elbow, Finger or Hand, and Ancle or foot.
Based on product segment, the global market is segmented into the knee, hip, shoulder, elbow, finger/hand, and ankle/foot.
The knee segment is further classified into primary knee replacement, partial knee replacement, custom-made replacements, revision knee replacement, and tumor.
By hip segment, the global endoprosthesis market is segmented into primary hip replacement, partial hip replacement, revision hip replacement, tumor, and custom-made partial pelvic replacements.
Based on the shoulder, the global endoprosthesis market is dispersed into primary shoulder replacement, revision shoulder replacements, tumor, and custom-made replacements.
In terms of the elbow, the global endoprosthesis market is segregated into total elbow replacement, radial head replacement, tumor, and custom-made replacements.
By finger/hand, the global endoprosthesis market is classified into total wrist prosthesis, (Proximal Interphalangeal) PIP finger prosthesis, and Metacarpophalangeal (MCP) finger prosthesis.
In terms of ankle/foot, the global endoprosthesis market is divided into total ankle implant and great toe implant.
Regional Analysis
North America held the largest market share in 2020. In North America, the endoprosthesis market is driven by the expanding reception of in fact progressed medical care items in the region and rising joint inflammation cases.
As indicated by the information distributed in the Centers for Disease Control and Prevention (CDC), the extended commonness of US grown-ups who are relied upon to report specialist analyzed joint pain is 67 million of every 2020, and by 2030, the number is projected to arrive at 72 million.
Accordingly, the district will request a compelling endoprosthesis gadget to conquer this sickness trouble. This factor is additionally projected to drive market development.
South America has seen extensive development in the endoprosthesis market and held a portion of the overall industry of 14.6% in 2020. Across South America, endoprosthesis rehearses are completed in various clinical offices, for example, government-controlled research facilities.
Monetarily autonomous patients frequently pick private research facility treatment. Brazil is one of the significant nations involving the biggest portion of the overall industry in the South American endoprosthesis market.
Prominent Players
The Major Companies Covered in this Report are Johnson & JohnsonServices, Inc.(US), Zimmer Biomet HoldingsInc.(US), Stryker(US), Smith & Nephew (UK), CorinLtd(UK), MedactaInternational SA(Switzerland), Exactech, Inc.(US), MicroPortOrthopedics,Inc.(US), A. (Switzerland), BraunMelsungenAG (Germany), Total Ankle Replacement (STAR; Small Bone Innovations, Morrisville, US), INBONE (Wright Medical Technology, Arlington, US),
Agility (DePuy, Warsaw, US), and Salto Talaris (Tornier, Montbonnot, France).
COVID 19 Impacts
We are continuously tracking the impact of the COVID-19 pandemic on various industries and verticals within all domains. Our research reports include the same and help you understand the drop and rise, owing to the impact of COVID-19 on the industries.
Also, we help you to identify the gap between the demand and supply of your interested market. Moreover, the report helps you with the analysis, amended government regulations, and many other useful insights.
Growing public awareness, and technological advancements in endoprosthesis devices are anticipated to fuel the growth of the global endoprosthesis market at a CAGR of 11.58% during the forecast period of 2021 to 2027
Table of Contents
TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING PREVALENCE OF OSTEOARTHRITIS AMONG THE GERIATRIC POPULATION
4.2.2 INCREASED INCIDENCES OF BONE FRACTURES
4.2.3 TECHNOLOGICAL ADVANCEMENTS IN ENDOPROSTHESIS DEVICES ENABLING EFFECTIVE TREATMENT
4.2.4 GROWING AWARENESS AMONG POPULATION
4.3 RESTRAINTS
4.3.1 ADVERSE EFFECTS ASSOCIATED WITH ENDOPROSTHESIS POST SURGERY
4.3.2 LACK OF HEALTHCARE INFRASTRUCTURE AND UNAFFORDABILITY IN EMERGING COUNTRIES
4.3.3 RESTRAINT IMPACT ANALYSIS
4.4 OPPORTUNITIES
4.4.1 RISING R&D INVESTMENTS FOR ENDOPROSTHESIS
4.4.2 INCREASING NUMBER OF PRODUCT LAUNCH, MERGER & ACQUISITION, AND EXPANSION
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION AND SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER’S FIVE FORCES MODEL
5.2.1 BARGAINING POWER OF SUPPLIERS
5.2.2 BARGAINING POWER OF BUYERS
5.2.3 THREAT OF NEW ENTRANTS
5.2.4 THREAT OF SUBSTITUTES
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE ENDOPROSTHESIS MARKET
5.3.1 OVERVIEW
5.3.2 IMPACT ON SUPPLY CHAIN
5.3.3 IMPACT ON MARKET
5.3.4 DEMAND-SUPPLY GAP ANALYSIS
6 GLOBAL ENDOPROSTHESIS MARKET BY PRODUCT
6.1 OVERVIEW
6.2 KNEE
6.3 HIP
6.4 SHOULDER
6.5 ELBOW
6.6 FINGER/HAND
6.7 ANKLE/FOOT
7 GLOBAL ENDOPROSTHESIS MARKET BY KNEE
7.1 OVERVIEW
7.2 PRIMARY KNEE REPLACEMENT
7.2.1 PRIMARY CEMENTED KNEE REPLACEMENT
7.2.2 PRIMARY CEMENTLESS KNEE REPLACEMENT
7.2.3 PRIMARY HYBRID KNEE REPLACEMENT
7.2.4 BCR (BI CRUCIATE-RETAINING) KNEE REPLACEMENT
7.2.4.1 PATELLA RESURFACING
7.2.4.2 COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT
7.2.4.3 UNCOATED KNEE REPLACEMENT
7.2.4.4 PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E)
7.2.5 MOBILE-BEARING
7.2.6 FIXED-BEARING
7.2.6.1 FIXED-BEARING WITH CEMENTED STEM
7.2.6.2 OTHERS
7.2.7 POSTERIOR STABILIZED
7.2.8 CRUCIATE-RETAINING
7.2.8.1 ULTRA-CONGRUENT OR CRUCIATE SUBSTITUTING
7.2.8.2 LATERAL PIVOT
7.2.8.3 MEDIAL PIVOT
7.3 PARTIAL KNEE REPLACEMENT
7.3.1 UNICOMPARTMENTAL PARTIAL KNEE REPLACEMENT
7.3.2 BICOMPARTMENTAL PARTIAL KNEE REPLACEMENT
7.3.3 PATELLO-FEMORAL PARTIAL KNEE REPLACEMENT
7.3.3.1 PATELLA RESURFACING
7.3.3.2 COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT
7.3.3.3 UNCOATED KNEE REPLACEMENT
7.3.3.4 PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E)
7.4 REVISION KNEE REPLACEMENT
7.4.1 COMPLETE NON-HINGED REVISION KNEE REPLACEMENT
7.4.2 COMPLETE HINGED REVISION KNEE REPLACEMENT
7.4.3 PARTIAL (FEMUR/TIBIAL/INSERT/PATELLA) REVISION KNEE REPLACEMENT
7.4.3.1 PATELLA RESURFACING
7.4.3.2 COATED (ANTI ALLERGIC COATINGS / CERAMIC COATINGS) KNEE REPLACEMENT
7.4.3.3 UNCOATED KNEE REPLACEMENT
7.4.3.4 PE-INLAY MATERIAL (UHMWPE / CROSSLINKED / VITAMIN E)
7.4.3.5 DEFECT FILLER (METAPHYSEAL)
7.5 TUMOR
7.5.1 PROXIMAL TIBIA REPLACEMENT
7.5.2 DISTAL FEMUR REPLACEMENT
7.6 CUSTOM MADE REPLACEMENT
7.6.1 GROWING PROSTHESIS
8 GLOBAL ENDOPROSTHESIS MARKET BY HIP
8.1 OVERVIEW
8.2 PRIMARY HIP REPLACEMENT
8.2.1 PRIMARY CEMENTED HIP REPLACEMENT
8.2.2 PRIMARY CEMENTLESS HIP REPLACEMENT
8.2.3 PRIMARY HYBRID HIP REPLACEMENT
8.2.3.1 DUAL MOBILITY CUP CEMENTED
8.2.3.2 DUAL MOBILITY CUP CEMENTLESS
8.2.4 HIP RESURFACING
8.2.5 TOTAL HIP RESURFACING
8.2.6 HEMI HIP RESURFACING
8.3 PARTIAL HIP REPLACEMENT
8.3.1 BIPOLAR PARTIAL HIP REPLACEMENT
8.3.2 UNIPOLAR PARTIAL HIP REPLACEMENT
8.3.3 ONE-PIECE ENDOPROSTHESIS PARTIAL HIP REPLACEMENT
8.4 CUSTOM HIP REPLACEMENTS
8.5 REVISION HIP REPLACEMENT
8.5.1 COMPLETE HIP REVISION
8.5.1.1 COMPLETE HIP REVISION WITH DUAL MOBILITY CUP
8.5.2 ACETABULAR COMPONENT REVISION
8.5.2.1 ACETABULAR COMPONENT REVISION WITH DUAL MOBILITY CUP
8.5.3 FEMORAL STEM REVISION
8.5.4 OTHER HIP REVISION
8.6 TUMOR
8.6.1 PROXIMAL FEMUR REPLACEMENT
9 GLOBAL ENDOPROSTHESIS MARKET BY SHOULDER
9.1 OVERVIEW
9.2 PRIMARY SHOULDER REPLACEMENT
9.2.1 PARTIAL SHOULDER REPLACEMENT
9.2.2 TOTAL/PRIMARY SHOULDER REPLACEMENT
9.2.3 REVERSE SHOULDER REPLACEMENT
9.2.4 SHOULDER RESURFACING
9.3 REVISION SHOULDER REPLACEMENTS
9.4 TUMOR
9.4.1 PROXIMAL HUMERUS REPLACEMENT
9.5 CUSTOM MADE REPLACEMENTS
10 GLOBAL ENDOPROSTHESIS MARKET BY ELBOW
10.1 OVERVIEW
10.2 TOTAL ELBOW REPLACEMENT
10.3 RADIAL HEAD REPLACEMENT
10.4 TUMOR
10.4.1 PROXIMAL ULNA REPLACEMENT
10.4.2 DISTAL HUMERUS REPLACEMENT
10.5 CUSTOM MADE REPLACEMENTS
11 GLOBAL ENDOPROSTHESIS MARKET BY FINGER/HAND
11.1 OVERVIEW
11.2 TOTAL WRIST PROTHESIS
11.3 PIP FINGER PROSTHESIS
11.4 MCP FINGER PROSTHESIS
11.4.1 CARPOMETACARPAL JOINT PROSTHESIS
11.4.2 OTHERS
12 GLOBAL ENDOPROSTHESIS MARKET BY ANKLE/FOOT
12.1 OVERVIEW
12.2 TOTAL ANKLE
12.3 GREAT TOE IMPLANT
13 GLOBAL ENDOPROSTHESIS MARKET, BY REGION
13.1 OVERVIEW
13.2 NORTH AMERICA
13.2.1 US
13.2.2 CANADA
13.2.3 MEXICO
13.3 SOUTH AMERICA
13.3.1 ARGENTINA
13.3.2 BRAZIL
13.3.3 COLOMBIA
13.3.4 PERU
13.3.5 CHILE
13.3.6 ECUADOR
13.3.7 REST OF SOUTH AMERICA
13.4 EUROPE
13.4.1 GERMANY
13.4.2 AUSTRIA
13.4.3 SWISS
13.4.4 FINLAND
13.4.5 DENMARK
13.4.6 NORWAY
13.4.7 SWEDEN
13.4.8 BELGIUM
13.4.9 FRANCE
13.4.10 NETHERLANDS
13.4.11 GREAT BRITAIN
13.4.12 CZECHIA
13.4.13 ITALIA
13.4.14 SPAIN
13.4.15 HUNGARY
13.4.16 IRELAND
13.4.17 PORTUGAL
13.4.18 POLAND
13.4.19 RUSSIA
13.4.20 ROMANIA
13.4.21 TURKEY
13.4.22 REST OF EUROPE
13.5 ASIA-PACIFIC
13.5.1 CHINA
13.5.2 JAPAN
13.5.3 INDIA
13.5.4 AUSTRALIA
13.5.5 SOUTH KOREA
13.5.6 TAIWAN
13.5.7 NEW ZEALAND
13.5.8 REST OF ASIA-PACIFIC
13.6 MIDDLE EAST & AFRICA
13.6.1 SAUDI ARABIA
13.6.2 UAE
13.6.3 EGYPT
13.6.4 ISRAEL
13.6.5 SOUTH AFRICA
13.6.6 SYRIA
13.6.7 REST OF MEA
14 COMPETITIVE LANDSCAPE
14.1 COMPETITIVEOVERVIEW
14.2 MAJOR PLAYERS IN THE GLOBAL ENDOPROSTHESIS MARKET
14.3 MAJOR GROWTH STRATEGIES IN THE GLOBAL ENDOPROSTHESIS MARKET
14.4 COMPETITIVE BENCHMARKING
14.5 LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE GLOBAL ENDOPROSTHESIS MARKET
14.6 KEY DEVELOPMENT ANALYSIS
14.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
14.7.1 NEW PRODUCT DEVELOPMENTS/LAUNCHES
14.7.2 COLLABORATIONS/ EXPANSIONS/PARTNERSHIPS/JOINT VENTURES
14.8 MAJOR PLAYERS FINANCIAL MATRIX
14.8.1 REVENUE OF MAJOR PLAYERS
14.8.2 R&D EXPENDITURE
15 COMPANY PROFILES
15.1 JOHNSON & JOHNSON SERVICES, INC.
15.1.1 COMPANY OVERVIEW
15.1.2 FINANCIAL OVERVIEW
15.1.3 PRODUCTS/SERVICES OFFERED
15.1.4 KEY DEVELOPMENTS
15.1.5 SWOT ANALYSIS
15.1.6 KEY STRATEGIES
15.2 ZIMMER BIOMET HOLDINGS INC.
15.2.1 COMPANY OVERVIEWS
15.2.2 FINANCIAL OVERVIEW
15.2.3 PRODUCTS/SERVICES OFFERED
15.2.4 KEY DEVELOPMENTS
15.2.5 SWOT ANALYSIS
15.2.6 KEY STRATEGIES
15.3 STRYKER
15.3.1 COMPANY OVERVIEW
15.3.2 FINANCIAL OVERVIEW
15.3.3 PRODUCTS/SERVICES OFFERED
15.3.4 KEY DEVELOPMENTS
15.3.5 SWOT ANALYSIS
15.3.6 KEY STRATEGIES
15.4 SMITH AND NEPHEW
15.4.1 COMPANY OVERVIEW
15.4.2 FINANCIAL OVERVIEW
15.4.3 PRODUCTS/SERVICES OFFERED
15.4.4 KEY DEVELOPMENTS
15.4.5 SWOT ANALYSIS
15.4.6 KEY STRATEGIES
15.5 WALDEMAR LINK GMBH & CO. KG
15.5.1 COMPANY OVERVIEW
15.5.2 FINANCIAL OVERVIEW
15.5.3 PRODUCTS/SERVICES OFFERED
15.5.4 KEY DEVELOPMENTS
15.5.5 SWOT ANALYSIS
15.5.6 KEY STRATEGIES
15.6 LIMACORPORATE SPA.
15.6.1 COMPANY OVERVIEW
15.6.2 FINANCIAL OVERVIEW
15.6.3 PRODUCTS/SERVICES OFFERED
15.6.4 KEY DEVELOPMENTS
15.6.5 SWOT ANALYSIS
15.6.6 KEY STRATEGIES
15.7 CORIN LTD
15.7.1 COMPANY OVERVIEW
15.7.2 FINANCIAL OVERVIEW
15.7.3 PRODUCTS OFFERED
15.7.4 KEY DEVELOPMENTS
15.7.5 SWOT ANALYSIS
15.7.6 KEY STRATEGIES
15.8 PETER BREHM GMBH
15.8.1 COMPANY OVERVIEW
15.8.2 FINANCIAL OVERVIEW
15.8.3 PRODUCTS OFFERED
15.8.4 KEY DEVELOPMENTS
15.8.5 SWOT ANALYSIS
15.8.6 KEY STRATEGIES
15.9 MATHYS LTD BETTLACH
15.9.1 COMPANY OVERVIEW
15.9.2 FINANCIAL OVERVIEW
15.9.3 PRODUCTS OFFERED
15.9.4 KEY DEVELOPMENTS
15.9.5 SWOT ANALYSIS
15.9.6 KEY STRATEGIES
15.10 B. BRAUN MELSUNGEN AG
15.10.1 COMPANY OVERVIEW
15.10.2 FINANCIAL OVERVIEW
15.10.3 PRODUCTS OFFERED
15.10.4 KEY DEVELOPMENTS
15.10.5 SWOT ANALYSIS
15.10.6 KEY STRATEGIES
15.11 MEDACTA INTERNATIONAL SA
15.11.1 COMPANY OVERVIEW
15.11.2 FINANCIAL OVERVIEW
15.11.3 PRODUCTS/SERVICES OFFERED
15.11.4 KEY DEVELOPMENTS
15.11.5 SWOT ANALYSIS
15.11.6 KEY STRATEGIES
15.12 EXACTECH, INC.
15.12.1 COMPANY OVERVIEW
15.12.2 FINANCIAL OVERVIEW
15.12.3 PRODUCTS OFFERED
15.12.4 KEY DEVELOPMENTS
15.12.5 SWOT ANALYSIS
15.12.6 KEY STRATEGIES
15.13 MICROPORT ORTHOPEDICS, INC.
15.13.1 COMPANY OVERVIEW
15.13.2 FINANCIAL OVERVIEW
15.13.3 PRODUCTS OFFERED
15.13.4 KEY DEVELOPMENTS
15.13.5 SWOT ANALYSIS
15.13.6 KEY STRATEGIES
15.14 TIPSAN
15.14.1 COMPANY OVERVIEW
15.14.2 FINANCIAL OVERVIEW
15.14.3 PRODUCTS OFFERED
15.14.4 KEY DEVELOPMENTS
15.14.5 SWOT ANALYSIS
15.14.6 KEY STRATEGIES
15.15 BAUMER SA.
15.15.1 COMPANY OVERVIEW
15.15.2 FINANCIAL OVERVIEW
15.15.3 PRODUCTS OFFERED
15.15.4 KEY DEVELOPMENTS
15.15.5 SWOT ANALYSIS
15.15.6 KEY STRATEGIES
15.16 IMPOL
15.16.1 COMPANY OVERVIEW
15.16.2 FINANCIAL OVERVIEW
15.16.3 PRODUCTS OFFERED
15.16.4 KEY DEVELOPMENTS
15.16.5 SWOT ANALYSIS
15.16.6 KEY STRATEGIES
15.17 GROUPE LEPINE
15.17.1 COMPANY OVERVIEW
15.17.2 FINANCIAL OVERVIEW
15.17.3 PRODUCTS OFFERED
15.17.4 KEY DEVELOPMENTS
15.17.5 SWOT ANALYSIS
15.17.6 KEY STRATEGIES
15.18 CONFORMIS
15.18.1 COMPANY OVERVIEW
15.18.2 FINANCIAL OVERVIEW
15.18.3 PRODUCTS OFFERED
15.18.4 KEY DEVELOPMENTS
15.18.5 SWOT ANALYSIS
15.18.6 KEY STRATEGIES
15.19 DJO
15.19.1 COMPANY OVERVIEW
15.19.2 FINANCIAL OVERVIEW
15.19.3 PRODUCTS OFFERED
15.19.4 KEY DEVELOPMENTS
15.19.5 SWOT ANALYSIS
15.19.6 KEY STRATEGIES
15.20 IMPLANTCAST
15.20.1 COMPANY OVERVIEW
15.20.2 FINANCIAL OVERVIEW
15.20.3 PRODUCTS OFFERED
15.20.4 KEY DEVELOPMENTS
15.20.5 SWOT ANALYSIS
15.20.6 KEY STRATEGIES
16 APPENDIX
16.1 REFERENCES
16.2 RELATED REPORTS
